rs1554991378
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001112741.2(KCNC1):c.1262C>T(p.Ala421Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001112741.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNC1 | NM_001112741.2 | c.1262C>T | p.Ala421Val | missense_variant | Exon 2 of 4 | ENST00000265969.8 | NP_001106212.1 | |
KCNC1 | NM_004976.4 | c.1262C>T | p.Ala421Val | missense_variant | Exon 2 of 2 | NP_004967.1 | ||
KCNC1 | XM_047426916.1 | c.1262C>T | p.Ala421Val | missense_variant | Exon 2 of 4 | XP_047282872.1 | ||
KCNC1 | XR_930866.3 | n.2484C>T | non_coding_transcript_exon_variant | Exon 2 of 3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727220
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Progressive myoclonic epilepsy type 7 Pathogenic:4
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNC1 protein function. ClinVar contains an entry for this variant (Variation ID: 488536). This missense change has been observed in individual(s) with clinical features of KCNC1-related disorder (PMID: 31353855, 31353862). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 421 of the KCNC1 protein (p.Ala421Val). Experimental studies have shown that this missense change affects KCNC1 function (PMID: 31353855, 31353862). For these reasons, this variant has been classified as Pathogenic. -
Variant summary: KCNC1 c.1262C>T (p.Ala421Val) results in a non-conservative amino acid change located in the Ion transport domain (IPR005821) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250990 control chromosomes. c.1262C>T, arising de novo, has been reported in the literature in multiple individuals affected with Epilepsy or Progressive Myoclonic Epilepsy 7 (examples, Kim_2021, Cameron_2019, Park_2019, Zhang_2019). These data indicate that the variant is very likely to be associated with disease. At least two publications report experimental evidence evaluating an impact on protein function, both of which suggest a loss-of-function effect of this variant (Cameron_2019, Park_2019). The following publications have been ascertained in the context of this evaluation (PMID: 31353855, 33349918, 31353862, 31216804). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
The observed missense variant c.1262C>T(p.Ala421Val) in KCNC1 gene has been reported previously in heterozygous state in multiple individuals with KCNC1-related disorders (Cameron JM, et al., 2019, Park J, et al., 2019). Experimental studies have shown that this missense change affects KCNC1 function (Cameron JM, et al., 2019). The c.1262C>T variant is absent in gnomAD Exomes. This variant has been reported to the ClinVar database as Likely Pathogenic/Pathogenic (multiple submissions). The amino acid Alanine at position 421 is changed to a Valine changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted to be damaging by SIFT. The amino acid change p.Ala421Val in KCNC1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
- -
Published functional studies demonstrate that p.(A421V) significantly affects Kv3.1 potassium channel function (Park et al., 2019; Cameron et al., 2019); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31216804, 32695065, 31785789, 33349918, Zhang2020[casereport], 33735526, 35618197, 31932120, 34733949, 33725338, 35840580, 34448338, 32655623, 31353862, 31353855) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at